VSIR and acute myeloid leukemia: The genetic deletion or antibody blockade of VISTA in both syngeneic and humanized AML mouse models significantly improved T cell–mediated immune clearance of AML cells, suggesting a role in both tumor cell–intrinsic and microenvironment-mediated immune suppression [195, 205].